April 30, 2019
UNC Lineberger’s Angela B. Smith, MD, MS, FACS, has been named director of Urologic Oncology in the UNC Department of Urology and co-director of the Multidisciplinary Genitourinary Oncology Service at the N.C. Cancer Hospital, UNC Lineberger’s clinical home.
May 21, 2018
In the journal Cancer Research, UNC Lineberger’s William Y. Kim, MD, Benjamin G. Vincent, MD, and colleagues reported they have developed a mouse model of luminal bladder cancer, one of the two subtypes of advanced bladder cancer. The researchers said this model may help them to determine which patients may respond to immunotherapy treatments called checkpoint inhibitors.
April 23, 2015
Siler City native Roger Johnson knows the value of personalized medicine. After being diagnosed with bladder cancer in 2013, physicians at UNC sequenced his tumor to better understand the genetics driving his cancer.
February 10, 2015
UNC Lineberger's Smith was awarded a contract by the Patient-Centered Outcomes Research Institute to find the research questions that matter most to bladder cancer patients.
July 8, 2014
The Bladder Cancer Advocacy Network (BCAN) has awarded William Kim, MD, associate professor of medicine, urology, and genetics, University of North Carolina at Chapel Hill and UNC Lineberger Comprehensive Cancer Center, with the 2014 Bladder Cancer Research Innovation Award to support his project “Immune Characterization of High-Grade Bladder Cancer.”
June 20, 2014
A story that ran on Raleigh-based CBS affiliate WRAL focuses on a new bladder cancer vaccine being studied at UNC, called Impact Therapy. The vaccine works to target cancer cells with minimal side effects.
May 5, 2014
Team UNC Lineberger participated in Saturday’s Bladder Cancer Advocacy Network’s (BCAN) Annual Walks for Bladder Cancer.
April 10, 2014
Please join Team Lineberger for the Bladder Cancer Advocacy Network (BCAN) annual walk to raise awareness about bladder cancer on May 3, 2014 in Hillsborough, NC.
February 11, 2014
A comprehensive genetic analysis of invasive bladder cancer tumors has found that the disease shares genetic similarities with two forms of breast cancer, according to researchers at the University of North Carolina Lineberger Cancer Center. Bladder cancer, which is the fourth most common malignancy in men and ninth most common in women in the United States, claimed more than 15,000 patients last year.
January 31, 2014
The journal highlights research performed by UNC Lineberger member Angela Smith, MD, that links a loss of muscle mass, known as sarcopenia, in women to complications from a cystectomy. Women who experienced sarcopenia were found to have a 43 percent chance of major complications compared to 10 percent for women who did not experience muscle loss.
